The nephrotoxin ochratoxin A induces apoptosis in cultured human proximal tubule cells

Cell Biology and Toxicology

Volumn 15, Issue 6, 1999, Pages 405-415

  Schwerdt, Gerald ^a   Freudinger, R ^a   Mildenberger, S ^a   Silbernagl, S ^a   Gekle, M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Caspase; DNA fragmentation; Immortalized human kidney epithelial cells; Nephrotoxicity; Renal cell lines

Indexed keywords

FREE RADICAL; MYCOTOXIN; OCHRATOXIN; REACTIVE OXYGEN METABOLITE;

APOPTOSIS; CALCIUM HOMEOSTASIS; CELL DEATH; CELL DIFFERENTIATION; CHROMATIN CONDENSATION; CONFERENCE PAPER; ENZYME ACTIVATION; EPITHELIUM CELL; HUMAN; HUMAN CELL; KIDNEY PROXIMAL TUBULE; LIPID PEROXIDATION; PRIORITY JOURNAL; PROTEIN BINDING;

ACETYLCYSTEINE; APOPTOSIS; CALCIUM; CASPASE 3; CASPASES; CELL LINE, TRANSFORMED; CHROMATIN; ENZYME ACTIVATION; HUMANS; KIDNEY TUBULES, PROXIMAL; MYCOTOXINS; OCHRATOXINS;

LETHRINIDAE;

EID: 0033501085     PISSN: 07422091     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007662101880     Document Type: Conference Paper

References (35)

1. Bahnemann E, Kerling H, Ensminger S, et al. Renal transepithelial secretion of ochratoxin A in the non-filtering toad kidney. Toxicology. 1997;120:11-7.
2. Chu FS. Interaction of ochratoxin A with bovine serum albumin. Arch Biochem Biophys. 1971;147:359-66.
3. Creppy EE, Lugnier AAJ, Fasiolo F, et al. In vitro inhibition of phenylalanyl-tRNA synthetase by ochratoxin A. Chem Biol Interact. 1979;24:257-61.
4. Dahlmann A, Dantzler WH, Silbernagl S, et al. Detailed mapping of ochratoxin A reabsorption along the rat nephron in vivo: the nephrotoxin can be reabsorbed in all nephron segments by different mechanisms. J Pharmacol Exp Ther. 1998;286:157-62.
5. Degen GH, Gerber MM, Obrecht-Pflumio S, et al. Induction of micronuclei with ochratoxin A in ovine seminal vesicle cell cultures. Arch Toxicol. 1997;71:365-71.
6. Enari M, Sakahira H, Yokoyama H, et al. A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature. 1998;391:43-50.
7. Gekle M, Wünsch S, Oberleithner H, et al. Characterization of two MDCK-cell subtypes as a model system to study principal cell and intercalated cell properties. Eur J Physiol. 1994;428:157-62.
8. Gekle M, Sauvant C, Schwerdt G, et al. Tubulotoxic mechanisms of ochratoxin A. Kidney Blood Press Res. 1998;21: 277-9.
9. Grosse Y, Baudrimont I, Castegnaro M, et al. Formation of ochratoxin A metabolites and DNA-adducts in monkey kidney cells. Chem Biol Interact. 1995;95:175-87.
10. Hoehler D, Marquardt RR, McIntosh AR, et al. Induction of free radicals in hepatocytes, mitochondria and microsomes of rats by ochratoxin A and its analogs. Biochim Biophys Acta. 1997;1357:225-33.
11. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 1972;26:239-57.
12. Kroemer G, Zamzami N, Susin SA. Mitochondrial control of apoptosis. Immunol Today. 1997;18:44-51.
13. Maaroufi K, Zakhama A, Baudrimont I, et al. Karyomegaly of tubular cells as early stage marker of the nephrotoxicity induced by ochratoxin A in rats. Hum Exp Toxicol. 1999;18: 410-15.
14. Mantle PG, Milijkovic A, Udupa V, et al. Does apoptosis cause renal atrophy in Balkan endemic nephropathy? Lancet. 1998;352:1118-9.
15. Martin SJ, Finucane DM, Amarante-Mendes GP, et al. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem. 1996;271:28753-6.
16. Meisner H, Chan S. Ochratoxin A, an inhibitor of mitochondrial transport systems. Biochemistry. 1974;13:2795-800.
17. Moore JH, Truelove B. Ochratoxin A: inhibition of mitochondrial respiration. Science. 1970;168:1102-3.
18. Nikolov IG, Petkova-Bocharova D, Castegnaro M, et al. Molecular and epidemiological approaches to the etiology of urinary tract tumors in an area with Balkan endemic nephropathy. J Environ Pathol Toxicol Oncol. 1996;15:201-7.
19. NTP. Third draft SCOOP report (C.N.T.M. task 3.2.2.). Assessment of dietary intake of ochratoxin A by the population of EU member states. C.N.T.M. task 3.2.2. Brussels: European Commission; 1997;1-45.
20. Omar RF, Hasinoff BB, Mejilla F, et al. Mechanism of ochratoxin A stimulated lipid peroxidation. Biochem Pharmacol. 1990;40:1183-91.
21. Rahimtula AD, Bereziat JC, Bussacchini-Griot V, et al. Lipid peroxidation as a possible cause of ochratoxin A toxicity. Biochem Pharmacol. 1988;37:4469-77.
22. Rahimtula AD, Chong X. Alterations in calcium homeostasis as a possible cause of ochratoxin A nephrotoxicity. IARC Sci Publ. 1991;207-14.
23. Sandau K, Pfeilschifter J, Brune B. Nitric oxide and superoxide induced p53 and Bax accumulation during mesangial cell apoptosis. Kidney Int. 1997;52:378-86.
24. Schlatter C, Studer-Rohr I, Rasonyi T. Carcinogenicity and kinetic aspects of ochratoxin A. Food Addit Contam. 1996; 13:43-4.
25. Schwerdt G, Freudinger R, Silbernagl S, et al. Ochratoxin A-binding proteins in rat organs and plasma and in different cell lines of the kidney. Toxicology. 1999;135:1-10.
26. Seegers JC, Böhmer LH, Kruger MC, et al. A comparative study on ochratoxin A-induced apoptosis in hamster kidney and HeLa cells. Toxicol Appl Pharmacol. 1994;129:1-11.
27. Stoev SD. The role of ochratoxin A as a possible cause of Balkan endemic nephropathy and its risk evaluation. Vet Hum Toxicol. 1998;40:352-60.
28. Sugiyama H, Kashihara N, Makino H, et al. Apoptosis in glomerular sclerosis. Kidney Int. 1996;49:103-11.
29. Thomas SE, Andoh TF, Pichler RH, et al. Accelerated apoptosis characterizes cyclosporine-associated interstitial fibrosis. Kidney Int. 1998;53:897-908.
30. i regulation in apoptosis, oncosis, and necrosis. Biochim Biophys Acta. 1996;1313:173-8.
31. Tveito G, Hansteen I, Dalen H, et al. Immortalization of normal human kidney epithelial cells by nickel(II). Cancer Res. 1989;49:1829-35.
32. Ueno Y, Umemori K, Niimi E, et al. Induction of apoptosis by T-2 toxin and other natural toxins in HL-60 human promyelotic leukemia cells. Nat Toxins. 1995;3:129-37.
33. Wafa EW, Yahya RS, Sobh MA, et al. Human ochratoxicosis and nephropathy in Egypt: a preliminary study. Hum Exp Toxicol. 1998;17:124-9.
34. Woo D. Apoptosis and loss of renal tissue in polycystic kidney diseases. N Engl J Med. 1995;333:18-25.
35. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature. 1980;284:555-6.